Limitations, agreements, and source contact

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer · Source last updated 2026-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

nfsaba@emory.edu

organization

Emory University

phone

404-778-1900

title

Dr. Nabil Saba

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice